Patents by Inventor Hiroki Yamaue

Hiroki Yamaue has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8703713
    Abstract: Described herein is a combination therapy suited to the treatment of pancreatic cancer and the like. Also described is a method of potentiating the therapeutic effect of chemotherapeutic agents such as gemcitabine.
    Type: Grant
    Filed: August 19, 2008
    Date of Patent: April 22, 2014
    Assignee: Onco Therapy Science, Inc.
    Inventor: Hiroki Yamaue
  • Publication number: 20140038966
    Abstract: This invention provides an antitumor agent comprising a combination drug containing tegafur, gimeracil, and oteracil potassium, characterized by being repeatedly administered to a patient once a day every other day, four days a week, at a dose such that the tegafur is administered in an amount of 80 mg or more/dose when the patient has a body surface area of less than 1.25 m2, in an amount of 100 mg or more/dose when the patient has a body surface area of 1.25 to 1.5 m2, or in an amount of 120 mg or more/dose when the patient has a body surface area of not less than 1.5 m2.
    Type: Application
    Filed: January 30, 2012
    Publication date: February 6, 2014
    Applicant: TAIHO PHARMACEUTICAL CO., LTD.
    Inventors: Tetsuhiko Shirasaka, Hiroki Yamaue, Susumu Yamamitsu
  • Publication number: 20110082088
    Abstract: Described herein is a combination therapy suited to the treatment of pancreatic cancer and the like. Also described is a method of potentiating the therapeutic effect of chemotherapeutic agents such as gemcitabine.
    Type: Application
    Filed: August 19, 2008
    Publication date: April 7, 2011
    Applicant: Oncotherapy Science, Inc.
    Inventor: Hiroki Yamaue